When it was announced in 2023 that the world’s first Crispr-based gene-editing therapy had been approved in the UK there was ...

Artificial intelligence (AI) isn't the only industry with explosive growth potential.

While artificial intelligence (AI) technology sweeps across the globe, reshaping industries from finance to ...

AI‑driven protein design creates potent anti‑CRISPR inhibitors that block Cas13 activity, offering a new potential tool for safer, more controlled gene editing.

CRISPR-Cas 9 is a gene-editing tool that made it possible to rewrite any organism's genetic code and tackle genetic diseases more effectively. Known as genetic scissors, CRISPR identifies a DNA ...

The rapid evolutionary dynamics of RNA viruses, driven by high mutation rates and the consequent formation of complex ...

CRISPR has the power to correct genetic mutations, but current delivery methods are either unsafe or inefficient, keeping the technology from reaching its full medical potential. With the power to ...

CRISPR-Cas9 genome editing enzyme. [Artur Plawgo / iStock / Getty Images Plus] We need a patient-first approach for any variant in any patient, whomever, wherever they are. Each and every patient ...

Torie Bosch is the First Opinion editor at STAT. Celena Lozano’s son Benny, who turned 5 in November, loves trains, trucks — anything that goes. He also has a rare disease, PURA syndrome. Earlier this ...

Researchers developed a CRISPR and single-molecule microarray test that quantifies Candida auris and detects antifungal ...